Cointime

Download App
iOS & Android

Neumora Therapeutics

company
Funding Round
Series B
Money Raised
$ 112M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Mubadala Capital Ventures - Yes - Detail
ARCH Venture Partners - - - Detail
Abu Dhabi Growth Fund - - - Detail
Altitude Life Science Ventures - - - Detail
Amgen - - - Detail
EXOR N.V. - - - Detail
F-Prime Capital - - - Detail
Invus - - - Detail
Newpath Management - - - Detail
Polaris Partners - - - Detail

Historical Financing

Announced Date Round Money Raised Investors
Oct 7, 2021 Series A $ 400M ARCH Venture Partners,Alexandria Venture Investments,etc. Detail
Oct 7, 2021 Corporate Round $ 100M Amgen Detail